Always a bridesmaid, never a bride: Committing to flu neuraminidase as a vaccine target

Cosette Schneider; Lynda Coughlan

doi:10.1016/j.ymthe.2023.04.014

Always a bridesmaid, never a bride: Committing to flu neuraminidase as a vaccine target

Cosette Schneider, Lynda Coughlan

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	1865-1867
Number of pages	3
Journal	Molecular Therapy
Volume	31
Issue number	7
DOIs	https://doi.org/10.1016/j.ymthe.2023.04.014
State	Published - 5 Jul 2023
Externally published	Yes

Access to Document

10.1016/j.ymthe.2023.04.014

Cite this

@article{52aa750144114e14a584d1d0b033b06d,

title = "Always a bridesmaid, never a bride: Committing to flu neuraminidase as a vaccine target",

author = "Cosette Schneider and Lynda Coughlan",

note = "Funding Information: The Coughlan lab is funded by National Institute of Allergy and Infectious Diseases (NIAID) grant ( R01AI148369 ), and by contract funding from NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs:  75N93019C00055). ",

year = "2023",

month = jul,

day = "5",

doi = "10.1016/j.ymthe.2023.04.014",

language = "English",

volume = "31",

pages = "1865--1867",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "7",

}

TY - JOUR

T1 - Always a bridesmaid, never a bride

T2 - Committing to flu neuraminidase as a vaccine target

AU - Schneider, Cosette

AU - Coughlan, Lynda

N1 - Funding Information: The Coughlan lab is funded by National Institute of Allergy and Infectious Diseases (NIAID) grant ( R01AI148369 ), and by contract funding from NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs:  75N93019C00055).

PY - 2023/7/5

Y1 - 2023/7/5

UR - http://www.scopus.com/inward/record.url?scp=85159611796&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2023.04.014

DO - 10.1016/j.ymthe.2023.04.014

M3 - Comment/debate

AN - SCOPUS:85159611796

SN - 1525-0016

VL - 31

SP - 1865

EP - 1867

JO - Molecular Therapy

JF - Molecular Therapy

IS - 7

ER -